Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety.

P E Levin

doi:10.2106/00004623-199411000-00021

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety.

P E Levin

https://doi.org/10.2106/00004623-199411000-00021

Copy DOI

Export

Save

Cite

Journal: The Journal of Bone & Joint Surgery	Publication Date: Nov 1, 1994
Citations: 15

#Prevention Of Deep Venous Thrombosis #Efficacy Of Enoxaparin #Use Of Enoxaparin #Elective Hip Replacement #Open-label Clinical Trial #Prevention Of Venous Thrombosis #Prevention Of Thrombosis #Clinical Trial #Open-label Trial #Deep Venous Thrombosis

Abstract
Full-Text
Similar Papers

Abstract

Listen

ABSTRACTA randomized, parallel-group, open-label clinical trial (the physicians, patients, and staff were not blinded with regard to the regimen that had been used) was conducted, between December 1988 and September 1990, to compare the safety and efficacy of enoxaparin, a low-molecular-weight hepar

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: The Journal of Bone & Joint Surgery

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety.